China A-share humanoid-robotics concept stocks rebounded; Zhaowei Mechatronics hit the daily limit, Tuosida rose over 10%, and Buke, Jack Technology, Huayi Technology, Inovance Technology, Fengli Intelligent and Orbbec also advanced.

Morgan Stanley lowers HP (HPQ.N) PT to $17.00 from $19.00.

Goldman Sachs says as humanoid robots move from technical validation to commercialization, supply‑chain investment is entering a phase of differentiation; investors should prioritise actual mass‑production progress, profitability and current valuation rather than blanket bullishness. The bank maintains Buy on Inovance Technology, Sanhua Intelligent Controls (H shares) and Shuanghuan Transmission; Neutral on Lvde Harmonic, Sanhua Intelligent Controls (A shares), Lingyun Optoelectronics and Beisite; and Sell on Mingzhi Electric. Goldman prefers firms with established core businesses that already support profits and can capture incremental robot demand, and is cautious on names whose valuations already price significant humanoid‑robot growth or that face technical‑route and margin uncertainty. Industry upside remains large, but markets are shifting focus to who can genuinely mass‑produce and deliver profits. (Goldman Sachs report, Aug. 23)